EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis

Fernando Martin-Moro, Miguel Alcoceba, Samuel Romero, Juan Marquet-Palomanes, David Alonso-Castronuño, Beatriz Astibia-Mahillo, Rafael Andreu, Rocio Perez-Alonso, Eulalia Rodriguez-Martin, Cristina De Ramon, Irene Solano, Alejandro Martin Garcia-Sancho und 9 weitere

Modern Pathology · 2026

DOI: 10.1016/j.modpat.2026.101009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Fernando Martin-Moro und 20 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, Ramon y Cajal University Hospital, Madrid, Spain; Ramon y Cajal Health Research Institute (IRYCIS), Madrid, Spain; Doctoral Pr…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, B-Lymphocytes, Lymphocytosis, Cell Transformation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche, Spanish Foundation of Hemotology and Hemotherapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Richter transformation diffuse large B-cell lymphoma type (DLBCL-RT) is a biologically complex process that requires a comprehensive workup for an accurate diagnosis. Detailed information regarding DLBCL-RT immunophenotype is limited. We used multiparametric flow cytometry and immunohistochemistry to assess the phenotypic profile of 63 patients diagnosed with DLBCL-RT. Cases partially retained the immunophenotype of the previous chronic lymphocytic leukemia (CLL), although modulation of markers, such as CD43, CD5, CD200, CD23, and CD38, was common. Moreover, the phenotype of DLBCL-RT differed according to prior exposure or not to CLL therapy, with treatment-naïve patients showing more immunophenotypic variations against prior CLL compared with those who received therapy before transformation. With respect to the prognostic impact of antigenic markers, cases expressing CD20 exhibited higher overall survival compared with CD20-negative cases, whereas CD43 expression was associated with worse prognosis. DLBCL-RT cases exhibited several antigenic differences in CLL-associated markers compared with an independent cohort of nontransformed DLBCL without concurrent CLL-like monoclonal B-cell lymphocytosis (MBL) (n = 28). In contrast, a separate cohort of patients with de novo DLBCL and concomitant CLL-like MBL (n = 25) exhibited biological similarities to DLBCL-RT, including comparable phenotypic profiles and a high rate of clonal relatedness between MBL and DLBCL. We conclude that DLBCL-RT is associated with a CLL-like immunophenotype influenced by pre-existing CLL characteristics, and we propose that, in some cases, de novo DLBCL with concomitant MBL may be considered as RT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseB-LymphocytesLymphocytosisCell Transformation, NeoplasticLeukemia, Lymphocytic, Chronic, B-CellHumansImmunophenotypingFlow CytometryPhenotypeImmunohistochemistryFemaleAgedBiomarkers, TumorMaleMiddle AgedAged, 80 and overAdultPrognosis

Stichwörter der Autor:innen

Richter transformationchronic lymphocytic leukemiadiffuse large B-cell lymphomaflow cytometryimmunohistochemistryimmunophenotyping

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Hematology Department, Ramon y Cajal University Hospital, Madrid, Spain; Ramon y Cajal Health Research Institute (IRYCIS), Madrid, Spain; Doctoral Program in Health Sciences, University of Alcala, Alcala de Henares, Spa…
  • Hematology Department, Hospital Universitario de Salamanca (HUS), Salamanca, Spain; Instituto de Investigacion Biomedica de Salamanca (IBSAL)/Centro de Investigacion del Cancer (CIC-IBMCC)/Universidad de Salamanca, Sala…
  • Hematology Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Instituto de Investigacion Sanitaria La Fe (IIS La Fe), Valencia, Spain.
  • Hematology Department, Ramon y Cajal University Hospital, Madrid, Spain; Ramon y Cajal Health Research Institute (IRYCIS), Madrid, Spain.
  • Hematology Department, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Ramon y Cajal Health Research Institute (IRYCIS), Madrid, Spain; Immunology Department, Ramon y Cajal University Hospital, Madrid, Spain.

Förderung

  • Roche
  • Spanish Foundation of Hemotology and Hemotherapy

Zitieren

APA

Martin-Moro, F., Alcoceba, M., Romero, S., Marquet-Palomanes, J., Alonso-Castronuño, D., Astibia-Mahillo, B., Andreu, R., Perez-Alonso, R., Rodriguez-Martin, E., De Ramon, C., Solano, I., Martin Garcia-Sancho, A., Piris-Villaespesa, M., Blanco, O., Roldan-Santiago, E., Garcia-Marco, J. A., Subira, D., Navarro-Bailon, A., Garcia-Cosio, M., …, & Lopez-Jimenez, J. (2026). Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.101009

Vancouver

Martin-Moro F, Alcoceba M, Romero S, Marquet-Palomanes J, Alonso-Castronuño D, Astibia-Mahillo B, et al. Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis. Modern Pathology. 2026. doi:10.1016/j.modpat.2026.101009

BibTeX
@article{MartinMoro2026,
  author = {Martin-Moro, Fernando and Alcoceba, Miguel and Romero, Samuel and Marquet-Palomanes, Juan and Alonso-Castronuño, David and Astibia-Mahillo, Beatriz and Andreu, Rafael and Perez-Alonso, Rocio and Rodriguez-Martin, Eulalia and De Ramon, Cristina and Solano, Irene and Martin Garcia-Sancho, Alejandro and Piris-Villaespesa, Miguel and Blanco, Oscar and Roldan-Santiago, Ernesto and Garcia-Marco, Jose A and Subira, Dolores and Navarro-Bailon, Almudena and Garcia-Cosio, Monica and Garcia-Vela, Jose A and Lopez-Jimenez, Javier},
  title = {Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis},
  journal = {Modern Pathology},
  year = {2026},
  doi = {10.1016/j.modpat.2026.101009}
}
Kostenlos starten →